Monographs

As used at Anderson Medical Specialty Associates and in the Bastyr University Clinical Research Center (BCRC).

GlutathioneUse in cell repair and augmentation of parenteral glutathione before and after administration:Rationale and formula developed for the BIORC – AMSA Clinics during the integrative oncology study.

Rationale and formula developed for the BIORC – AMSA Clinics during the integrative oncology study.

Question: I have been told that we should wait two or more years after platinum based chemotherapy to begin any detoxification. But I have now heard conflicting information – has something changed?

A seeming conundrum regarding the ability of some leukemic cells (i.e. CLL) to sequester ascorbate (ASC) has led to confusion regarding the safety and utility of high dose ascorbate delivered via IV (HDIVC). This has led to some apparent confusion between this concern and the apparent positive benefits of HDIVC seen in clinical practice.

For whatever reasons this gem of an old paper is making a resurgence at many oncologists offices and being used as a justification to not start IVC, HDIVC etc.

Updated Data Review and Policies for concurrent use at Anderson Medical Specialty Associates, Southwest College of Naturopathic Medicine Research Institute and Medical Center and Bastyr University Clinical Research Center

HDIVC in cases of marginal GFR:

General Treatment Protocol for the use of Intravenous Ascorbic Acid as used by Bastyr University Clinical Research Center (BCRC) and Anderson Medical Specialty Associates

The following four IV Vitamin C formulas are used for oxidative therapies.

In an interventional study associated with BIORC and AMSA we attempted to answer the questions regarding electrolyte shifts and HDIVC administration.

Oxidative versus Non-oxidative dosing of High and Low Dose Intravenous Ascorbic Acid as used by Bastyr University Clinical Research Center (BCRC) and Anderson Medical Specialty Associates (AMSA)